54092-063Level 3
Agrylin (anagrelide hydrochloride)
**Product type:** Human Prescription Drug
**Active ingredient:** ANAGRELIDE HYDROCHLORIDE ANHYDROUS
**Strength:** .5 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Takeda Pharmaceuticals America, Inc.
**Marketing category:** NDA (NDA020333)
**Pharmacologic class:** Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]
GET
/api/v1/systems/ndc_fda/nodes/54092-063Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.